Based on the Gleason score, T stage, and prostate-specific antigen (PSA) level, we observed no discernible bias in organoid establishment when comparing the stratification of all tumor tissue samples with that of established patient-derived PC organoid lines (Fig 1F). This evidence concerns the gene KLK3 and neoplasm.